Brief: Dermata Therapeutics Says As Of June 30, Co Had $427,202 In Cash
Sept 27 (Reuters) - Dermata Therapeutics Inc DRMA.O :
* DERMATA THERAPEUTICS - AS OF JUNE 30, 2021, CO HAD
$427,202 IN
CASH
* DERMATA THERAPEUTICS INC QTRLY NET LOSS PER COMMON SHARE,
BASIC
AND DILUTED $0.70
Further company coverage: DRMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dermata Therapeutics
See all newsNASDAQ RESUMED AT 10:31 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM
Brief: Dermata Therapeutics - To Launch First Commercial Product Tome Foundational Treatment On August 25, 2026
Dermata Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dermata Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview